Page last updated: 2024-11-04

sibutramine and Genetic Predisposition

sibutramine has been researched along with Genetic Predisposition in 2 studies

sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride

Research Excerpts

ExcerptRelevanceReference
" We describe the case of a 46-year-old female patient presenting with a first episode of symptomatic porphyria after 10 d of sibutramine treatment for weight loss."7.76Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss. ( Eickmann, S; Finckh, U; Haverkamp, T; Reiser, M, 2010)
" We describe the case of a 46-year-old female patient presenting with a first episode of symptomatic porphyria after 10 d of sibutramine treatment for weight loss."3.76Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss. ( Eickmann, S; Finckh, U; Haverkamp, T; Reiser, M, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reiser, M1
Eickmann, S1
Haverkamp, T1
Finckh, U1

Other Studies

2 other studies available for sibutramine and Genetic Predisposition

ArticleYear
Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss.
    Obesity reviews : an official journal of the International Association for the Study of Obesity, 2010, Volume: 11, Issue:4

    Topics: Appetite Depressants; Cyclobutanes; Female; Flavoproteins; Genetic Predisposition to Disease; Humans

2010
[Extra pounds despite sports and diets. Genetics can also be involved].
    MMW Fortschritte der Medizin, 2002, May-09, Volume: 144, Issue:19

    Topics: Appetite Depressants; Combined Modality Therapy; Cyclobutanes; Diet, Reducing; Energy Metabolism; Ge

2002